• DisperSol, Catalent Enter Manufacturing Collaboration contractpharma
    August 04, 2021
    ​DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics ...
  • Lupin to approach USFDA for reinspection of key plants in next few months expresspharma
    June 15, 2020
    Reportedly, regulatory action by the USFDA has impacted several new approvals, thus affecting the company's business in various regions including the US that remains the single-largest pharma market globally.
PharmaSources Customer Service